Add-Ons How Does Jenny Craig Compare to Other Meal Delivery Services
The latest research and trials on the effect of GLP-1RAs in the eye were searched until April 2025, including thorough cellular studies, animal studies, and clinical observation surrounding glaucoma, diabetic retinopathy, and other ocular diseases
Accessed April 16, 2024 .] GLP-1s Past, Present and Future Given the recent craze, it may surprise some that the GLP-1 drug Saxenda ( liraglutide ) was approved by the FDA for weight reduction in people without T2D 10 years ago
It is not licensed by the MHRA and remains in Phase 3 clinical trials, with one programme expected to conclude in May 2026 [5][6]
If and when approvals happen, NHS access would follow a separate NICE appraisal
Fast Processing: We strive to ship same-day